(19)
(11)
EP 0 845 994 A1
(12)
(43)
Date of publication:
10.06.1998
Bulletin 1998/24
(21)
Application number:
96928798.0
(22)
Date of filing:
06.08.1996
(51)
International Patent Classification (IPC):
A61K
38/
00
( . )
A61K
38/
20
( . )
A61P
37/
06
( . )
A61K
31/
00
( . )
A61P
37/
00
( . )
(86)
International application number:
PCT/US1996/012538
(87)
International publication number:
WO 1997/005896
(
20.02.1997
Gazette 1997/09)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
LT LV
(30)
Priority:
09.08.1995
US 19950002057
20.03.1996
US 19960619958
(71)
Applicant:
SCHERING CORPORATION
Kenilworth, NJ 07030 (US)
(72)
Inventor:
TADMORI, Waleed
Berkeley Heights, NJ 07922 (US)
(74)
Representative:
Ritter, Stephen David, et al
Mathys & Squire 100 Grays Inn Road
London WC1X 8AL
London WC1X 8AL (GB)
(54)
COMBINED USE OF INTERLEUKIN-10 AND CYCLOSPORIN FOR IMMUNOSUPPRESSION THERAPY